Home LiteratureArticle Details
PMID: 2791805 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program.

Digestive diseases and sciences ·Vol. 34 ·No. 10 ·1989-10-00 ·Pages 1536-41

Lashner BA, Silverstein MD, Hanauer SB

Abstract

The risk of colon cancer in patients with ulcerative colitis is related to the duration and extent of disease. Prior reports have suggested that patients with onset of disease in childhood have a high risk of cancer. These risk factors were analyzed in 99 patients in a surveillance program of annual colonoscopy to detect mucosal dysplasia. All patients had pancolitis for at least eight years. The mean age at symptom onset was 23.2 years and the mean duration of disease at entry was 17 years. An average of 4.2 tests/patient were performed, and 91% were completely followed through 1985. Cancer risk was expressed as the hazard rate or the annual probability that a patient free of cancer would develop cancer after survival to a given time period. The hazard rate for high-grade dysplasia or cancer in patients with pancolitis measured from symptom onset was 2.5% at 20 years, 4% at 25 years, 7% at 30 years, 13% at 35 years, and 20% at 40 years. Sex was not a significant predictor of cancer, but older age at symptom onset was a predictor of dysplasia and cancer. From these data, the annual hazard rate of developing high-grade dysplasia or cancer can be estimated in patients with pancolitis based on an individual's age at symptom onset and duration of disease.

MeSH Terms
Age Factors Carcinoma/epidemiology,etiology Colitis, Ulcerative/complications,pathology Colonic Neoplasms/epidemiology,etiology Colonoscopy Female Humans Intestinal Mucosa/pathology Male Prospective Studies Risk Factors Survival Analysis Time Factors
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Lashner B A
Department of Medicine, University of Chicago Medical Center, Illinois.
Silverstein M D
Hanauer S B
References (27)
27 references, click to expand
  1. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy.
    Gastroenterology. 1981 Feb;80(2):366-74 PMID: 7450425
  2. Dysplasia and malignancy in inflammatory bowel disease.
    Annu Rev Med. 1984;35:33-48 PMID: 6372661
  3. Prevalence and incidence of inflammatory bowel disease in family members.
    Gastroenterology. 1986 Dec;91(6):1396-400 PMID: 3770366
  4. Carcinoma and epithelial dysplasia complicating ulcerative colitis.
    Gastroenterology. 1975 May;68(5 Pt 1):1127-36 PMID: 1126593
  5. Mortality in ulcerative colitis.
    Gastroenterology. 1982 Jul;83(1 Pt 1):36-43 PMID: 7075944
  6. Mucosal dysplasia. A major predictor of cancer following ileorectal anastomosis.
    Dis Colon Rectum. 1983 Nov;26(11):697-700 PMID: 6628140
  7. Cancer risk in ulcerative colitis: scientific requirements for the study of prognosis.
    Gastroenterology. 1980 Jun;78(6):1632-5 PMID: 7372078
  8. "Precancer" lesions in ulcerative colits. A retrospective study of rectal biopsy and colectomy specimens.
    Cancer. 1974 Sep;34(3):suppl:835-44 PMID: 4847943
  9. Optimal timing of colonoscopy to screen for cancer in ulcerative colitis.
    Ann Intern Med. 1988 Feb;108(2):274-8 PMID: 3124681
  10. Cancer in colitis: assessment of the individual risk by clinical and histological criteria.
    Gastroenterology. 1977 Dec;73(6):1280-9 PMID: 913969
  11. Villous dysplasia. An ominous histologic sign in colitic patients.
    Dis Colon Rectum. 1984 May;27(5):283-7 PMID: 6714042
  12. Surveillance for colonic carcinoma in ulcerative colitis.
    Gastroenterology. 1985 Dec;89(6):1342-6 PMID: 4054527
  13. Colonoscopy and the detection of dysplasia in patients with longstanding ulcerative colitis.
    Lancet. 1980 Sep 20;2(8195 pt 1):620-2 PMID: 6107410
  14. The occurrence of severe epithelial dysplasia and its bearing on treatment of longstanding ulcerative colitis.
    Ann Surg. 1982 Feb;195(2):209-13 PMID: 7055398
  15. Precancerous lesions in the mucosa in ulcerative colitis. A radiographic, endoscopic, and histopathologic study.
    Scand J Gastroenterol. 1980;15(3):289-96 PMID: 7433888
  16. Macroscopic lesions in dysplasia and carcinoma complicating ulcerative colitis.
    Dig Dis Sci. 1983 Jan;28(1):18-26 PMID: 6822178
  17. Malignant potential of chronic ulcerative colitis. Preliminary report.
    Gastroenterology. 1979 Jan;76(1):1-5 PMID: 758130
  18. Use of the hazard rate to schedule follow-up exams efficiently. An optimization approach to patient management.
    Med Decis Making. 1983;3(2):229-44 PMID: 6633190
  19. Cancer risk and life expectancy of children with ulcerative colitis.
    N Engl J Med. 1971 Jul 1;285(1):17-21 PMID: 5089367
  20. Cancer in universal and left-sided ulcerative colitis: factors determining risk.
    Gastroenterology. 1979 Aug;77(2):290-4 PMID: 447042
  21. Cancer surveillance in ulcerative colitis. Experience over 15 years.
    Lancet. 1983 Jul 16;2(8342):149-52 PMID: 6134993
  22. Current status of the precancer lesion in ulcerative colitis.
    Gastroenterology. 1977 Dec;73(6):1431-3 PMID: 913984
  23. Dysplasia and cancer in inflammatory bowel disease.
    Gastroenterology. 1981 Apr;80(4):865-8 PMID: 7202956
  24. Assessment of colorectal cancer risk in patients with ulcerative colitis: experience from a private practice.
    Gastroenterology. 1983 Jul;85(1):22-9 PMID: 6852458
  25. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.
    Hum Pathol. 1983 Nov;14 (11):931-68 PMID: 6629368
  26. Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review.
    N Engl J Med. 1987 Jun 25;316(26):1654-8 PMID: 3295551
  27. Cancer morbidity in ulcerative colitis.
    Gut. 1982 Jun;23(6):490-7 PMID: 7076024
Article Info
Journal
Digestive diseases and sciences
Abbr.
Dig Dis Sci
ISSN
0163-2116
Published
1989-10-00
Pages
1536-41
Language
English
Region
United States
NLM ID
7902782
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com